CURE Pharmaceutical has agreed to acquire Chemistry Holdings Inc., a formulation technology company that is developing innovative delivery systems for a variety of industries, in an all-stock transaction. “This transaction will create a pioneering drug delivery engine with the promise to transform patient experience and wellness,” said Rob Davidson, chief executive officer of CURE Pharmaceutical. “We believe that our combined talent, technology and capital will allow us to execute our bus...